Targeting macrophage endocytosis via platelet membrane coating for advanced osteoimmunomodulation

• DOI: 10.1016/j.isci.2022.105196
• Publication Date: 2022-09-23T17:40:06Z
• Authors: Wendong Gao; Lan Xiao; Yuqing Mu; Yin Xiao
• Keywords: 570; 0303 health sciences; Science & Technology; BIOACTIVE GLASSES; Science; Drug delivery system; Immunology; Q; 610; Health sciences; Clinical sciences; Nanobiotechnology; Article; Multidisciplinary Sciences; Biological sciences; 03 medical and health sciences; Science & Technology - Other Topics; APOPTOTIC CELL CLEARANCE; Medicine

The identification, uptake, and clearance of nanoparticles (NPs) by phagocytes are critical in NP-based therapeutics. The cell membrane coating technique has recently emerged as an ideal surface modification approach to help NP bypass phagocytosis. CD47, a regulatory protein for phagocytosis, is a cell surface glycoprotein expressed on all cell types, including platelets. Herein, we enclosed bioactive glass (BG) with a platelet membrane to bestow BG with unique cell surface functions for immune evasion and immunomodulation. Compared with the uncoated particles, platelet membrane-coated BG shows reduced cellular uptake and can generate an immune environment favorable for osteogenesis. This is evidenced by the triggering of robust osteogenic differentiation in bone mesenchymal stromal cells, suggesting the synergistic effect of platelet membrane and BG in bone regeneration. These collectively indicate that cell membrane coating is a promising approach to enhance the therapeutic efficacy of biomaterials and thus provide new insight into biomaterial-mediated bone regeneration.